MHRA Drug Safety Update July 2019

MHRA Drug Safety Update July 2019

July 18, 2019

Date issued: 17th July 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 12 July 2019) has been published and includes articles on:

  • Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease
  • Tocilizumab (RoActemra): rare risk of serious liver injury including cases requiring transplantation
  • Rivaroxaban (Xarelto▼): reminder that 15 mg and 20 mg tablets should be taken with food
  • Letters and drug alerts sent to healthcare professionals in June 2019
  • Medical Device Alerts issued in June 2019

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

July edition of CPN magazine is out

The July 2019 edition of PSNC’s Community Pharmacy News (CPN) is now available. This month’s CPN features: Five-year funding settlement;...